跳至主要内容
临床试验/NCT04794192
NCT04794192进行中(未招募)不适用

Assessment of the Ankle Systolic Pressure Index in Patients Over 70 Years of Age With Jaundice Ulcer

Fondation Hôpital Saint-Joseph1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2019年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
53
试验地点
1
主要终点
To evaluate the diagnostic performance of toe IPSI by laser-doppler, as a screening test for ALL in patients over 70 years of age, non-diabetic and non-renal failure, compared to the data of the considered Doppler ultrasound as the gold standard

研究概览

简要总结

Arteriopathy of the lower limbs (ALL) is defined by a decreased ankle perfusion pressure with a systolic pressure index (SPI) <0.9, and constitutes the most advanced situation in terms of cardiovascular prognosis with in 20 % of cases of lesions associated with the heart and / or coronary heart. The severity of ALL is linked to the risk of a cardiovascular event, hence the need for a hemodynamic evaluation which is mainly based on the measurement of SPI.

详细描述

However, the presence of mediacalcosis, making the arteries incompressible, limits the interpretation of IPS. However, ALL affects 50% of diabetic patients after 20 years of disease with predominant involvement in the infra-popliteal gland consisting mainly of mediacalcosis, but often respecting the arteries of the foot.

The recommendations of the French-speaking Association for the Study of Diabetes and Metabolic Diseases in 1997 and of the American Diabetes Association in 2001, recommended the SPI and the realization of ultrasound for the diagnosis of ALL. Some authors have shown that SPI can be falsely normal with 4.3 times more false negative ankle SPI in diabetics compared to the general population. This is why this measurement of the SPI is coupled with the measurement of the pressure of the big toe (PGT) or even the transcutaneous measurement of the oxygen pressure (TcPO2) as recommended by the American Heart Association (AHA) and the American College of Cardiology (ACC) in 2005, in case of uninterpretable IPS.

The subjects at risk of mediacalcosis are: diabetics, renal insufficiency and the very elderly.

A recent thesis work confirmed that the SPI alone was not reliable as a screening tool in diabetic patients, with good sensitivity of the measurement of PGT.

What about a population over the age of 70, without diabetes and without kidney failure?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man or woman aged> 70 hospitalized in the vascular medicine department of the Paris Saint-Joseph Hospital Group
  • French-speaking patient

排除标准

  • Patient with treated or untreated diabetes
  • Renal failure (GFR CKD-EPI or MDRD <60ml / min)
  • ATCD revascularization or amputation
  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient objecting to participation in the study
  • Patient under legal protection.

结局指标

主要结局

To evaluate the diagnostic performance of toe IPSI by laser-doppler, as a screening test for ALL in patients over 70 years of age, non-diabetic and non-renal failure, compared to the data of the considered Doppler ultrasound as the gold standard

时间窗: Day 1

Sensitivity and specificity of laser-doppler toe PSI for screening ALL in patients over 70 years of age.

次要结局

  • Number of participants with presence of hypertension(Day 1)
  • Number of smokers among the participants(Day 1)
  • Relationship between ankle SPI and lower limb arterial disease risk factors(Day 1)
  • Determination of the sex of the population(Day 1)
  • Number of participants with treatments(Day 1)
  • Determination of the age of the population(Day 1)
  • Search for predictive factors associated with ankle SPI for the diagnosis of arteriopathy of the lower limbs(Day 1)
  • Number of participants with cardiovascular history(Day 1)
  • Relationship between toe SPI and risk factors for arterial disease of the lower limbs(Day 1)
  • Search for predictive factors associated with toe SPI for the diagnosis of arteriopathy of the lower limbs(Day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验